In an exceptional year for biotech and pharma, there were so many outstanding CEOs, I couldn’t single out just one for my 2025 Best Biopharma CEO honor.

Here are this year’s winners: 

The dealmakers 

2025 has been the best year for biotechs being acquired by pharma companies since 2019, with nearly $240 billion worth of deals announced or closed through November, according to Stifel.

Continue to STAT+ to read the full story…